| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Sharp Phillip A is a Director at SYRS with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 28 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 11,250 | $275.00 | $3,093,750.00 | -100% | -12.2% | +29.9% | |
| Feb 29, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $151.34 | $4,540,070.94 | -55.5% | -2.8% | +63.3% | |
| Aug 15, 2022 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 33,670 | $230.49 | $7,760,736.28 | -26.8% | -7.6% | -22.0% | |
| Feb 9, 2022 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $150.00 | $4,500,000.00 | -100% | -15.3% | +42.4% | |
| Nov 25, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $124.89 | $3,746,749.17 | -3.0% | - | - | |
| Feb 12, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $130.00 | $3,900,000.00 | -11.3% | - | - | |
| Nov 18, 2019 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $91.71 | $1,375,661.70 | -2.0% | - | - | |
| Apr 15, 2019 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $88.23 | $1,323,442.00 | -1.6% | - | - | |
| Mar 13, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $149.00 | $2,235,000.00 | -9.6% | - | - | |
| Mar 9, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $129.00 | $1,935,000.00 | -9.6% | - | - |